NCT07627672Not yet recruiting
Effectiveness of Patch-Electrocardiogram Recorders in Screening for Atrial Fibrillation in Elderly People in the Chinese Community
Effectiveness of Patch-Electrocardiogram Recorders in Screening for Atrial Fibrillation in Elderly People in the Chinese Community: A Prospective Multicenter Study
Source: ClinicalTrials.gov · Last updated 4 Jun 2026
Brief summary (registry, in English)
This prospective, multicenter, single-arm study evaluates the effectiveness of a single-lead patch electrocardiogram (ECG) recorder in screening for atrial fibrillation (AF) among community-dwelling elderly individuals aged ≥60 years in China. Participants will undergo 7 days of continuous ECG monitoring, followed by annual follow-up for up to 10 years to assess long-term outcomes including stroke, heart failure, and death.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 30000 (estimated)
- First submitted
- 31 May 2026
- Start date
- 1 Sept 2026
- Primary completion date
- 1 Sept 2036
- Lead sponsor
- Beijing Anzhen Hospital
- Diseases
- Atrial fibrillation
- NCT number
- NCT07627672
What you commit to
- Study type: Interventional
- Planned participants: 30000
- From 1 Sept 2026 to the primary completion date, 1 Sept 2036
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previously diagnosed with atrial fibrillation and already receiving treatment
Other illness
- Severe cognitive impairment or inability to cooperate with follow-up assessments
Other
- Pregnant or breastfeeding women
Who the study is looking for
- Age ≥60 years
- No prior diagnosis of atrial fibrillation
- Able to understand the study purpose and willing to provide written informed consent
- No severe cardiac disease, acute illness, or contraindication to ECG monitoring
- Able to wear the patch ECG device and comply with continuous monitoring requirements
Age in the registry: 60 years to - · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.